A detailed history of Peoples Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Peoples Bank holds 2,605 shares of LLY stock, worth $2.1 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
2,605
Previous 2,383 9.32%
Holding current value
$2.1 Million
Previous $1.85 Million 27.25%
% of portfolio
1.23%
Previous 1.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $160,921 - $201,806
222 Added 9.32%
2,605 $2.36 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $11,844 - $15,845
20 Added 0.85%
2,383 $1.85 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $69,986 - $96,487
-161 Reduced 6.38%
2,363 $1.27 Million
Q2 2023

Jul 28, 2023

SELL
$350.74 - $468.98 $1,753 - $2,344
-5 Reduced 0.2%
2,524 $1.18 Million
Q1 2023

Apr 24, 2023

SELL
$310.63 - $364.82 $7,144 - $8,390
-23 Reduced 0.9%
2,529 $868,000
Q4 2022

Jan 31, 2023

SELL
$321.55 - $374.67 $38,586 - $44,960
-120 Reduced 4.49%
2,552 $933,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $4,447 - $5,068
15 Added 0.56%
2,672 $864,000
Q1 2022

May 03, 2022

SELL
$234.69 - $291.66 $23,469 - $29,166
-100 Reduced 3.63%
2,657 $761,000
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $4,497 - $5,580
-20 Reduced 0.72%
2,757 $762,000
Q3 2021

Oct 27, 2021

SELL
$221.6 - $272.71 $1,108 - $1,363
-5 Reduced 0.18%
2,777 $642,000
Q2 2021

Aug 02, 2021

SELL
$180.55 - $233.54 $55,067 - $71,229
-305 Reduced 9.88%
2,782 $639,000
Q1 2021

Apr 19, 2021

BUY
$164.32 - $212.72 $20,047 - $25,951
122 Added 4.11%
3,087 $577,000
Q4 2020

Feb 01, 2021

SELL
$130.46 - $172.63 $37,181 - $49,199
-285 Reduced 8.77%
2,965 $500,000
Q3 2020

Oct 23, 2020

SELL
$146.22 - $169.13 $5,848 - $6,765
-40 Reduced 1.22%
3,250 $481,000
Q2 2020

Jul 27, 2020

BUY
$136.42 - $164.18 $5,456 - $6,567
40 Added 1.23%
3,290 $540,000
Q1 2020

May 01, 2020

SELL
$119.05 - $147.35 $23,452 - $29,027
-197 Reduced 5.72%
3,250 $450,000
Q4 2019

Jan 28, 2020

SELL
$106.92 - $132.43 $10,798 - $13,375
-101 Reduced 2.85%
3,447 $453,000
Q3 2019

Oct 18, 2019

SELL
$106.79 - $116.16 $21,998 - $23,928
-206 Reduced 5.49%
3,548 $397,000
Q2 2019

Aug 07, 2019

BUY
$110.79 - $129.32 $13,959 - $16,294
126 Added 3.47%
3,754 $416,000
Q1 2019

May 06, 2019

SELL
$111.31 - $131.02 $10,797 - $12,708
-97 Reduced 2.6%
3,628 $471,000
Q4 2018

Feb 26, 2019

BUY
$105.9 - $118.64 $15,885 - $17,796
150 Added 4.2%
3,725 $431,000
Q3 2018

Oct 31, 2018

SELL
$85.86 - $107.31 $17,172 - $21,462
-200 Reduced 5.3%
3,575 $384,000
Q2 2018

Jul 27, 2018

BUY
$75.7 - $86.88 $3,785 - $4,344
50 Added 1.34%
3,775 $322,000
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $10,760 - $12,702
-145 Reduced 3.75%
3,725 $289,000
Q3 2017

Oct 23, 2017

BUY
$77.07 - $85.54 $298,260 - $331,039
3,870
3,870 $331,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Peoples Bank Portfolio

Follow Peoples Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Bank , based on Form 13F filings with the SEC.

News

Stay updated on Peoples Bank with notifications on news.